Align Technology | ALGN - 销售收入



金融业
股票价格
USD
资产
USD 6.42B
现金及等价物
USD 1.1B
销售成本
USD 298.76M
流动资产
USD 2.66B
流动负债
USD 1.91B
债务
USD 116.04M
EBIT
USD 191.32M
EBITDA
USD 229.14M
员工
20.95K
EPS每股收益
USD 2.64
股本和储备
USD 4.23B
销售毛利
USD 757.43M
债务利息支出
USD 6.93M
利息收入
USD 3.91M
贷款资金
USD 0
市值
USD 11.86B
净收入
USD 108.29M
营业费用
USD 864.87M
营业利润
USD 191.32M
普通股股本
USD 71.62M
PE价格收益
21.81
税前利润
USD 148.69M
销售收入
USD 1.06B
销售和管理费用
USD 462.67M
股票
USD 212.24M
贸易债权人
USD 109.84M
应收帐款人
USD 1.15B


销售 更改 日
3M USD 6.5B 500M 2026-06
Align Technology USD 1.06B 20M 2026-06
Becton, Dickinson and Co. USD 5B 300M 2026-06
Bruker USD 838.5M 15.1M 2026-06
Cardinal Health USD 63.7B 2.8B 2026-06
Charles River Laboratories USD 1000M 4.2M 2026-06
Cooper Companies USD 1.08B 57.4M 2026-03
CVS Health USD 106.1B 5.7B 2026-06
Danaher USD 6.3B 350M 2026-06
Dentsply International USD 898M 18M 2026-06
Dexcom USD 1.31B 120M 2026-06
Henry Schein USD 3.46B 90M 2026-06
Idexx Laboratories USD 1.22B 80M 2026-06
Insulet USD 801.7M 40M 2026-06
Integra LifeSciences USD 418.8M 26.9M 2026-06
IQVIA Holdings USD 4.37B 220M 2026-06
McKesson USD 105.38B 13.08B 2026-06
Mettler Toledo International USD 1.03B 82.87M 2026-06
Revvity USD 729.68M 18.68M 2026-06
Solventum Corp USD 2.2B 190M 2026-06
Stryker USD 6.6B 600M 2026-06
Teleflex USD 570.3M 22M 2026-06
Thermo Fisher Scientific USD 11.99B 980M 2026-06
Veeva Systems USD 927.96M 45.02M 2026-06
Waters USD 1.64B 370M 2026-06
Zimmer Biomet Holdings USD 2.18B 90M 2026-06
Zoetis USD 2.5B 200M 2026-06